|
|
|||||||
 |
|
|
LinkBack | Thread Tools | Display Modes |
09-17-2010, 01:48 AM
|
|||
|
|||
Spirogen, Celtic Therapeutics announces initiation of Phase II ovarian cancer trial w
Spirogen Limited and Celtic Therapeutics Holdings LP announced today the commencement of a Phase II clinical trial of SG2000 in ovarian cancer. The trial is being sponsored by the National Cancer Institute of the USA, and is now actively recruiting patients for treatment.
    
|
|
| Thread Tools | |
| Display Modes | |
|
|
Similar Threads
|
||||
| Thread | Thread Starter | Forum | Replies | Last Post |
| Celldex Therapeutics Announces Initiation of Randomized Phase 2 Clinical Trial of CDX | cancerfr | Bladder Cancer | 0 | 05-17-2010 10:01 PM |
| Symphogen Announces Initiation Of Phase 1/2 Trial Of Sym004 In Patients With Advanced | cancerfr | Extracranial Germ Cell Tumor | 0 | 04-05-2010 11:30 PM |
| Symphogen Announces Initiation of Phase 1/2 Trial of Sym004 in Patients with Advanced | cancerfr | Extracranial Germ Cell Tumor | 0 | 04-01-2010 07:13 AM |
| Portola Pharmaceuticals Announces Initiation Of Phase 1 Clinical Trial Of PRT062607, | cancerfr | Leukemia | 0 | 03-24-2010 03:38 PM |
| Portola Pharmaceuticals Announces Initiation Of Phase 1 Clinical Trial Of PRT062607, | cancerfr | Non-Hodgkin Lymphoma | 0 | 03-24-2010 03:38 PM |
Linear Mode
